Recent advances in the development of oxytocin receptor antagonists

Current Pharmaceutical Design

Volumn 2, Issue 1, 1996, Pages 41-58

  Williams, P D ^a   Pettibone, D J ^b  

^a Department of Medicinal Chemistry ^*  (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001929988     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dale, H. H. J. Physiol. 1906, 34, 163-206.
2. Ott, J.; Scott, J. C. Proc. Soc. Exp. Biol. Med. 1910, 8, 48-56.
3. du Vigneaud, V.; Ressler, C.; Trippelt, S. J. Biol. Chem. 1953, 205, 949-957.
4. du Vigneaud, V.; Ressler, C.; Swan, J. M.; Roberts, C. W.; Katsoyannis, P. G.; Gordon, S. J. Am. Chem. Soc. 1953, 75, 4879-4880.
5. Caldeyro-Barcia, R.; Poseiro, J. J. New York Acad. Sci. 1959, 75, 813-830.
6. Embrey, M. P.; Moir, J. C. J. Obstet. Gynecol Br Comm. 1967, 74, 648-652.
7. Meites, J.; Nicoll, C. S.; Talwalker, P. K. Proc. Soc. Endocrinol. Biol. Med. 1960, 103, 118-122.
8. DeNuccio, D. J.; Grosvenor, C. E. Am. J. Physiol. 1967, 212, 149-156.
9. Crowley, W. R.; Armstrong, W. E. Endocr. Rev. 1992, 13, 33-65.
10. van Leengoed, E.; Kerker, E.; Swanson, H. H. J. Endocrinol 1987, 112, 275-282.
11. Argiolas, A.; Gessa, G. L. Neurosci. Biobehav. Rev. 1991, 15, 217-231.
12. Wmslow, J. T.; Shapiro, L.; Carter, S., Insel, T. R. Psychopharm. Bull 1993, 29, 409-414.
13. Argiolas, A.; Melis, M. R.: Gessa, G. L. Eur. J. Pharmacol. 1986, 130, 265-272.
14. Witt, D. M.; Insel, T. R. Ann. N.Y. Acad. Sci. 1992, 652, 445-447.